Growth factors adsorbed on polyglycolic acid mesh augment growth of bioengineered intestinal neomucosa.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Surgical Research

• Publication date

  2011-08-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1016/j.jss.2009.11.719PMID 20444471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats.

  2017cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche

  2009cited by this paper
• Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.

  2009cited by this paper
• Cellular iron transport.

  2009cited by this paper
• Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.

  2009cited by this paper
• Intestinal Stem Cell Organoid Transplantation Generates Neomucosa in Dogs

  2009cited by this paper
• The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.

  2008cited by this paper
• The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine.

  2008cited by this paper
• Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds.

  2008cited by this paper
• Life in the crypt: a role for glucagon-like peptide-2?

  2008cited by this paper
• Modulation of protein delivery from modular polymer scaffolds.

  2007cited by this paper
• Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.

  2006cited by this paper
• Orthotopic transplantation of intestinal mucosal organoids in rodents.

  2006cited by this paper
• New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome

  2006cited by this paper
• Polymers, drug release, and drug-eluting stents.

  2006cited by this paper
• The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.

  2006cited by this paper
• Prolonged maintenance of neointestine using subcutaneously implanted tubular scaffolds in a rat model.

  2006cited by this paper
• Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.

  2005cited by this paper
• Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

  2005cited by this paper
• Matrigel: basement membrane matrix with biological activity.

  2005influential reference
• Treatment of bile acid malabsorption using ileal stem cell transplantation.

  2005cited by this paper
• Morphology and growth of murine cell lines on model biomaterials.

  2004cited by this paper
• Tissue-Engineered Small Intestine Improves Recovery After Massive Small Bowel Resection

  2004cited by this paper
• Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.

  2004cited by this paper
• THE EFFECT OF GLP-2 ON MUCOSAL MORPHOLOGY AND SGLT 1 EXPRESSION IN TISSUE-ENGINEERED NEOINTESTINE

  2003cited by this paper
• Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography1

  2003cited by this paper
• Tissue Regeneration Based on Growth Factor Release

  2003cited by this paper
• The surgical management of short bowel syndrome

  2002cited by this paper
• Biological actions and therapeutic potential of the glucagon-like peptides.

  2002cited by this paper
• Glucagon-Like Peptide 2 Stimulates Intestinal Epithelial Proliferation In Vitro

  2002cited by this paper
• Tissue-engineered small intestine: Ontogeny of the Immune System12

  2001cited by this paper
• Growth factor release from tissue engineering scaffolds

  2001cited by this paper
• GLP-2 as therapy for the short-bowel syndrome.

  2001cited by this paper
• New frontiers in the biology of GLP-2.

  2000cited by this paper
• Epidermal growth factor is critical for intestinal adaptation following small bowel resection

  2000cited by this paper
• Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis

  2000cited by this paper
• Growth-factor enhancement of compromised gut function following massive small-bowel resection

  2000cited by this paper
• Transferrin receptor activity and localisation in the rat duodenum

  2000cited by this paper
• Effect of insulin-like growth factor I on in vivo intestinal absorption of d-galactose in cirrhotic rats.

  1999cited by this paper
• Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo.

  1999cited by this paper
• A mouse model of intestinal stem cell function and regeneration.

  1999cited by this paper
• Epidermal growth factor augments adaptation following small bowel resection: Optimal dosage, route, and timing of administration: C.E. Shin, M.A. Helmrath, R.A. Falcone Jr, et al. J Surg Res 77:11–16, (June), 1998

  1999cited by this paper
• Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo

  1998cited by this paper
• GLP-2 augments the adaptive response to massive intestinal resection in rat.

  1998cited by this paper
• Intestinal Epithelial‐Mesenchymal Cell Interactions

  1998cited by this paper
• Epidermal growth factor augments adaptation following small bowel resection: optimal dosage, route, and timing of administration.

  1998cited by this paper
• Enhancement of intestinal adaptation by hepatocyte growth factor.

  1998cited by this paper
• Intestinal growth-promoting properties of glucagon-like peptide-2 in mice.

  1997cited by this paper
• Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2.

  1997cited by this paper
• Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo.

  1997influential reference
• Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2.

  1997cited by this paper
• Advances in the management of patients with intestinal failure.

  1996cited by this paper
• Intestinal adaptation following massive small bowel resection in the mouse.

  1996cited by this paper
• Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix.

  1996cited by this paper
• Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors.

  1995cited by this paper
• Does neomucosa induced by small bowel stem cell transplantation have adequate function?

  1995cited by this paper
• Growth factor regulation of proliferation in primary cultures of small intestinal epithelium

  1995cited by this paper
• Hepatocyte growth factor region specifically stimulates gastro-intestinal epithelial growth in primary culture.

  1995cited by this paper
• Colonic mucosal replacement by syngeneic small intestinal stem cell transplantation.

  1994cited by this paper
• The endocytosis of transferrin by rat intestinal epithelial cells.

  1994cited by this paper
• Epidermal growth factor primes intestinal epithelial cells for proliferative effect of insulin-like growth factor I

  1994cited by this paper
• Hepatocyte Growth Factor Region Specifically Stimulates Gastrointestinal Epithelial Growth in Primary Culture

  1994cited by this paper
• Surgical management of short bowel syndrome.

  1993cited by this paper
• Basement membrane components enhance isolated enterocyte growth.

  1992cited by this paper
• Proliferation and differentiation of fetal rat intestinal epithelial cells in primary serum-free culture.

  1992cited by this paper
• Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres

  1991cited by this paper
• Localization of hepatocyte growth factor in human and rat tissues: An immunohistochemical study

  1991cited by this paper
• Immunolocalization of transferrin and transferrin receptor in mouse small intestinal absorptive cells.

  1990cited by this paper
• Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

  1988cited by this paper
• Influence of epidermal growth factor on intestinal function in the rat: comparison of systemic infusion versus luminal perfusion.

  1988cited by this paper
• Stimulation of neomucosal growth by systemic urogastrone.

  1987cited by this paper
• The importance of luminal factors in neomucosal growth.

  1986cited by this paper
• Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

  1984cited by this paper
• THE SURGICAL SIGNIFICANCE OF THE ILEOCECAL JUNCTION.

  1964cited by this paper

• Tissue engineering and regenerative medicine approaches in colorectal surgery

  2024cites this paper
• Composite Scaffolds Based on Intestinal Extracellular Matrices and Oxidized Polyvinyl Alcohol: A Preliminary Study for a New Regenerative Approach in Short Bowel Syndrome

  2018influential citation
• Production of tissue-engineered intestine from expanded enteroids.

  2016cites this paper
• HB-EGF embedded in PGA/PLLA scaffolds via subcritical CO2 augments the production of tissue engineered intestine.

  2016cites this paper
• Multiplication of the Enterocyte Mass by Serosal Patch Technique / Umnožavanje Enterocitne Mase Tehnikom Seroznog Patch-A

  2015cites this paper
• Intestinal stem cells and stem cell-based therapy for intestinal diseases

  2015cites this paper
• Generation of tissue-engineered small intestine using embryonic stem cell-derived human intestinal organoids

  2015cites this paper
• Emerging translational research on magnetic nanoparticles for regenerative medicine.

  2015cites this paper
• The action of mimetic peptides on connexins protects fibroblasts from the negative effects of ischemia reperfusion

  2015cites this paper
• Building Blocks for Engineering the Small Intestine

  2014cites this paper
• Stem cells and biopharmaceuticals: vital roles in the growth of tissue-engineered small intestine.

  2014cites this paper
• The Journal of Surgical Research – 2012

  2012cites this paper
• The Journal of Surgical Research Editorial Board – 2011

  2011cites this paper